The Klinique Medical Clinic PCLBKK:KLINIQ 88 ROE % is 26.42% as of Mar. 2026, which is 21% above its 10-year median of 21.80. GuruFocus rates BKK:KLINIQ with a GF Score™ of 88/100 and a GF Value™ of ฿44.60 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 92 Personal Services companies, The Klinique Medical Clinic PCL ranks better than 79.35% on this metric.
BKK:KLINIQ'
s ROE % Range Over the Past 10 Years
Min: 17.24 Med: 21.8 Max: 95.13
Current: 22.55
During the past 7 years, The Klinique Medical Clinic PCL's highest ROE % was 95.13%. The lowest was 17.24%. And the median was 21.80%.
BKK:KLINIQ's ROE % is ranked better than 79.35% of 92
companies
in the Personal Services industry
Industry Median: 6.15
vs BKK:KLINIQ: 22.55
The Klinique Medical Clinic PCL (BKK:KLINIQ) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
The Klinique Medical Clinic PCL ROE % Related Terms
The Klinique Medical Clinic PCL ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Personal Services subindustry, The Klinique Medical Clinic PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Klinique Medical Clinic PCL ROE % vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, The Klinique Medical Clinic PCL's ROE % distribution charts can be found below:
* The bar in red indicates where The Klinique Medical Clinic PCL's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a ROE % of 26.42% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on The Klinique Medical Clinic PCL and its competitors. This is 21% above median its historical median of 21.80. Over the past decade, The Klinique Medical Clinic PCL's ROE % has ranged from 17.24 to 95.13. According to the industry distribution chart, The Klinique Medical Clinic PCL ranks #19 out of 92 companies in the Personal Services industry, placing it in the top 20.7%.
Is The Klinique Medical Clinic PCL's ROE % too high?
The Klinique Medical Clinic PCL's current ROE % of 26.42% is 21% above median its 10-year median of 21.80. Over the past 10 years, this metric has ranged from a low of 17.24 to a high of 95.13. The Personal Services industry median ROE % is 6.15. The Klinique Medical Clinic PCL's value of 26.42% is 329.6% above this industry median. Based on the distribution chart, The Klinique Medical Clinic PCL ranks #19 out of 92 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's ROE % compare to ROL and SCI?
According to the Personal Services industry distribution chart, The Klinique Medical Clinic PCL ranks #19 out of 92 companies for ROE %. This places The Klinique Medical Clinic PCL in the top 21% of its industry — outperforming the majority of peers. The industry median ROE % is 6.15. The Klinique Medical Clinic PCL's value of 26.42% is 329.6% above this benchmark. Historically, The Klinique Medical Clinic PCL's own ROE % has ranged from 17.24 to 95.13 over the past decade. While the company's 10-year median is 21.80 vs. the industry median of 6.15, The Klinique Medical Clinic PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Personal Services company?
The median ROE % among Personal Services companies is 6.15, based on 92 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Klinique Medical Clinic PCL's current ROE % of 26.42% is 329.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on The Klinique Medical Clinic PCL and its competitors. For the Personal Services industry, the median ROE % is 6.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Klinique Medical Clinic PCL's current ROE % is 26.42%, which is 21% above median its own 10-year median of 21.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿44.60, compared to a current price of ฿25.75 — trading 42.3% below its estimated fair value. The current ROE % is 26.42%, which is 21% above median its 10-year median of 21.80 and 329.6% above the Personal Services industry median of 6.15. The Klinique Medical Clinic PCL's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current ROE % is 26.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued.
The current stock price of ฿25.75 is trading 42.3% below its estimated GF Value™ of ฿44.60.
GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.
Key valuation signals for BKK:KLINIQ:
ROE %: 26.42% (21% above median its 10-year median of 21.80)
GF Value™: ฿44.60 vs. price of ฿25.75 (42.3% below fair value)
Industry Position: 329.6% above the Personal Services median (#19 of 92)
No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Klinique Medical Clinic PCL Business Description
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
88GF Score
Get the complete analysis for BKK:KLINIQ
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KLINIQ has been successfully added to your 
